 <h1>Fensolvi Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>leuprolide</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about leuprolide. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Fensolvi.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to leuprolide: powder for suspension 1 month, powder for suspension 3 month, powder for suspension 4 month, powder for suspension 6 month, solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, leuprolide (the active ingredient contained in Fensolvi) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking leuprolide:</p><p>
<i>For adults</i>
</p><p>
<i>Less common</i>
</p><ul>
<li>Fast or irregular heartbeat</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Bone, muscle, or joint pain</li>
<li>fainting</li>
<li>fast or irregular breathing</li>
<li>numbness or tingling of the hands or feet</li>
<li>puffiness or swelling of the eyelids or around the eyes</li>
<li>skin rash, hives, or itching</li>
<li>sudden, severe decrease in blood pressure and collapse</li>
<li>tightness in the chest</li>
<li>trouble breathing</li>
</ul><p>
<i>For males only (adults)</i>
</p><p>
<i>More common</i>
</p><ul>
<li>Arm, back, or jaw pain</li>
<li>bloody or cloudy urine</li>
<li>blurred vision</li>
<li>chest pain or discomfort</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty with moving</li>
<li>dizziness</li>
<li>frequent urge to urinate</li>
<li>headache</li>
<li>increased urge to urinate during the night</li>
<li>muscle pain or stiffness</li>
<li>nausea</li>
<li>nervousness</li>
<li>pain in the joints</li>
<li>pale skin</li>
<li>pounding in the ears</li>
<li>slow or fast heartbeat</li>
<li>sweating</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>waking to urinate at night</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Pain in the groin or legs (especially in the calves)</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Altered mental status</li>
<li>cold, clammy, pale skin</li>
<li>confusion</li>
<li>double vision</li>
<li>irregular heartbeat</li>
<li>visual changes</li>
<li>vomiting</li>
</ul><p>
<i>For females only (adults)</i>
</p><p>
<i>Rare</i>
</p><ul>
<li>Anxiety</li>
<li>deepening of voice</li>
<li>increased hair growth</li>
<li>mental depression</li>
<li>mood changes</li>
</ul><p>
<i>For children</i>
</p><p>
<i>More common</i>
</p><ul>
<li>Body aches or pain</li>
<li>chills</li>
<li>cough</li>
<li>cough producing mucus</li>
<li>difficulty in breathing</li>
<li>ear congestion</li>
<li>fever</li>
<li>headache</li>
<li>loss of voice</li>
<li>muscle aches</li>
<li>noisy breathing</li>
<li>pain or redness at the injection site</li>
<li>runny or stuffy nose</li>
<li>sneezing</li>
<li>sore throat</li>
<li>tightness in the chest</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Irritability</li>
<li>mood or mental changes</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Burning, itching, or swelling at the injection site</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Seizures</li>
</ul><p>
<i>For females only (children)â€”expected in first few weeks</i>
</p><p>
<i>Rare</i>
</p><ul>
<li>Vaginal bleeding (continuing)</li>
<li>white vaginal discharge (continuing)</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of leuprolide may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>For adults</i>
</p><p>
<i>More common</i>
</p><ul>
<li>Sudden sweating and feeling of warmth (hot flashes)</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bleeding, bruising, burning, itching, pain, redness, or swelling at the injection site</li>
<li>decreased interest in sexual intercourse</li>
<li>swelling of the feet or lower legs</li>
<li>swelling or increased tenderness of the breasts</li>
<li>trouble sleeping</li>
<li>weight gain</li>
</ul><p>
<i>For females only (adults)</i>
</p><p>
<i>More common</i>
</p><ul>
<li>Light, irregular vaginal bleeding</li>
<li>stopping of menstrual periods</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Burning, dryness, or itching of the vagina</li>
<li>pelvic pain</li>
</ul><p>
<i>For males only (adults)</i>
</p><p>
<i>More common</i>
</p><ul>
<li>Back pain</li>
<li>chills</li>
<li>constipation</li>
<li>cough</li>
<li>diarrhea</li>
<li>fever</li>
<li>general feeling of discomfort or illness</li>
<li>loss of appetite</li>
<li>pain or discomfort at the injection site</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>runny nose</li>
<li>shivering</li>
<li>sore throat</li>
<li>unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Decreased size of the testicles</li>
<li>inability to have or keep an erection</li>
</ul><p>
<i>For children</i>
</p><p>
<i>More common</i>
</p><ul>
<li>Constipation</li>
<li>feeling of warmth</li>
<li>nausea</li>
<li>redness of the face, neck, arms and occasionally, upper chest</li>
<li>stomach pain</li>
<li>vomiting</li>
</ul><p>
<!-- end powder for suspension 1 month, powder for suspension 3 month, powder for suspension 4 month, powder for suspension 6 month, solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to leuprolide: intramuscular kit, intramuscular powder for injection, intramuscular powder for injection extended release, subcutaneous implant, subcutaneous kit, subcutaneous powder for injection extended release, subcutaneous solution</i></p><h3>General</h3><p>The most commonly reported side effects were general pain, peripheral edema, hot flashes, hair loss, ECG changes, ischemia.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Anaphylactic reactions (e.g., rash, pruritus, urticaria, wheezing or interstitial pneumonitis, anaphylactic reactions)<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Vaginal dryness (37%), breast tenderness (14%), libido decreased, erectile dysfunction, testicular atrophy</p>
<p><b>Common</b> (1% to 10%): Urinary frequency/urgency, hematuria, urinary tract infection, ovarian hyperstimulation, testicular soreness/pain, breast soreness/tenderness, penile disorder, vaginal hemorrhage, gynecomastia, breast changes, breast enlargement, decrease in testicular size, impotence</p>
<p><b>Frequency not reported</b>: Urinary tract obstruction<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): ECG changes (19%), ischemia (19%), hot flush</p>
<p><b>Common</b> (1% to 10%): Hypertension, murmur, phlebitis, thrombosis, arrhythmias, angina, myocardial infarction<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Hot flashes (91%)</p>
<p><b>Very rare</b> (less than 0.01%): Pituitary apoplexy</p>
<p><b>Frequency not reported</b>: Transient increase in serum testosterone concentrations during the first 2 days of therapy, 'flare' phenomenon<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression, insomnia/sleep disorder, anxiety, nervousness, mood changes, decreased libido, increased libido<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness/lightheadedness, headache (sometimes severe) </p>
<p><b>Uncommon</b> (0.1% to 1%): Paresthesia</p>
<p><b>Very rare</b> (less than 0.01%): Pituitary apoplexy (following initial administration in patients with pituitary adenoma)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, nausea/vomiting, flatulence, dyspepsia, gastroenteritis/colitis, diarrhea, dysphagia, GI bleeding, GI disturbance, peptic ulcer, rectal polyps<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Hair loss (18%), hyperhidrosis</p>
<p><b>Common</b> (1% to 10%): Skin rash, acne, itching, dry skin, ecchymosis, pruritus, photosensitivity, clamminess, night sweats, skin pigmentation<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Bone/joint pain, myalgia, ankylosing spondylosis, arthritis, blurred disc margins, bone fracture, muscle stiffness, muscle weakness/tenderness, pelvic fibrosis, spasms/cramps</p>
<p><b>Uncommon</b> (0.1% to 1%): Myalgia, weakness of lower extremities</p>
<p><b>Frequency not reported</b>: Backache, muscle atrophy, limb pain</p>
<p><b>Postmarketing reports</b>: Spinal fracture/paralysis, tenosynovitis-like symptoms<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia</p>
<p><b>Postmarketing reports</b>: Decreased white blood cell count (WBC)</p>
<p><b>Frequency not reported</b>: Decreased red blood cell count (RBC)/hematocrit/hemoglobin, thrombocytopenia, leucopenia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea, sinus congestion, chest tightness, decreased breathing sounds, hemoptysis, pleuritic chest pain, pulmonary infiltrate, rales/rhonchi, rhinitis, strep throat, wheezing/bronchitis, pulmonary edema, pulmonary embolism</p>
<p><b>Frequency not reported</b>: Interstitial lung disease (ILD)<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Erythema, ecchymosis, induration, abscess, pain, swelling, nodules, ulcers, irritation, necrosis at the site of injection<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Tinnitus, general pain, edema peripheral</p>
<p><b>Frequency not reported</b>: Disturbance of smell/taste, vertigo</p>
<p><b>Postmarketing reports</b>: Hearing disorder<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Hepatitis, hepatomegaly, jaundice</p>
<p><b>Postmarketing reports</b>: Hepatic dysfunction<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Anorexia</p>
<p><b>Frequency not reported</b>: Weight gain/loss</p>
<p><b>Postmarketing reports</b>: Diabetes<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Visual impairment</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Lupron (leuprolide)." TAP Pharmaceuticals Inc, Deerfield, IL. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Are Lupron Depot and Eligard the same drug?</li>
<li>Will I get my period while on Lupron?</li>
<li>What does this drug do for IVF?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Fensolvi (leuprolide)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>Drug class: gonadotropin releasing hormones</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Lupron, Eligard, Lupron Depot, Lupron Depot-PED, Viadur</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Precocious Puberty</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to leuprolide: intramuscular kit, intramuscular powder for injection, intramuscular powder for injection extended release, subcutaneous implant, subcutaneous kit, subcutaneous powder for injection extended release, subcutaneous solution</i></p><h3>General</h3><p>The most commonly reported side effects were general pain, peripheral edema, hot flashes, hair loss, ECG changes, ischemia.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Anaphylactic reactions (e.g., rash, pruritus, urticaria, wheezing or interstitial pneumonitis, anaphylactic reactions)<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Vaginal dryness (37%), breast tenderness (14%), libido decreased, erectile dysfunction, testicular atrophy</p><p><b>Common</b> (1% to 10%): Urinary frequency/urgency, hematuria, urinary tract infection, ovarian hyperstimulation, testicular soreness/pain, breast soreness/tenderness, penile disorder, vaginal hemorrhage, gynecomastia, breast changes, breast enlargement, decrease in testicular size, impotence</p><p><b>Frequency not reported</b>: Urinary tract obstruction<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): ECG changes (19%), ischemia (19%), hot flush</p><p><b>Common</b> (1% to 10%): Hypertension, murmur, phlebitis, thrombosis, arrhythmias, angina, myocardial infarction<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Hot flashes (91%)</p><p><b>Very rare</b> (less than 0.01%): Pituitary apoplexy</p><p><b>Frequency not reported</b>: Transient increase in serum testosterone concentrations during the first 2 days of therapy, 'flare' phenomenon<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression, insomnia/sleep disorder, anxiety, nervousness, mood changes, decreased libido, increased libido<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness/lightheadedness, headache (sometimes severe) </p><p><b>Uncommon</b> (0.1% to 1%): Paresthesia</p><p><b>Very rare</b> (less than 0.01%): Pituitary apoplexy (following initial administration in patients with pituitary adenoma)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, nausea/vomiting, flatulence, dyspepsia, gastroenteritis/colitis, diarrhea, dysphagia, GI bleeding, GI disturbance, peptic ulcer, rectal polyps<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Hair loss (18%), hyperhidrosis</p><p><b>Common</b> (1% to 10%): Skin rash, acne, itching, dry skin, ecchymosis, pruritus, photosensitivity, clamminess, night sweats, skin pigmentation<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Bone/joint pain, myalgia, ankylosing spondylosis, arthritis, blurred disc margins, bone fracture, muscle stiffness, muscle weakness/tenderness, pelvic fibrosis, spasms/cramps</p><p><b>Uncommon</b> (0.1% to 1%): Myalgia, weakness of lower extremities</p><p><b>Frequency not reported</b>: Backache, muscle atrophy, limb pain</p><p><b>Postmarketing reports</b>: Spinal fracture/paralysis, tenosynovitis-like symptoms<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia</p><p><b>Postmarketing reports</b>: Decreased white blood cell count (WBC)</p><p><b>Frequency not reported</b>: Decreased red blood cell count (RBC)/hematocrit/hemoglobin, thrombocytopenia, leucopenia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea, sinus congestion, chest tightness, decreased breathing sounds, hemoptysis, pleuritic chest pain, pulmonary infiltrate, rales/rhonchi, rhinitis, strep throat, wheezing/bronchitis, pulmonary edema, pulmonary embolism</p><p><b>Frequency not reported</b>: Interstitial lung disease (ILD)<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Erythema, ecchymosis, induration, abscess, pain, swelling, nodules, ulcers, irritation, necrosis at the site of injection<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Tinnitus, general pain, edema peripheral</p><p><b>Frequency not reported</b>: Disturbance of smell/taste, vertigo</p><p><b>Postmarketing reports</b>: Hearing disorder<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Hepatitis, hepatomegaly, jaundice</p><p><b>Postmarketing reports</b>: Hepatic dysfunction<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Anorexia</p><p><b>Frequency not reported</b>: Weight gain/loss</p><p><b>Postmarketing reports</b>: Diabetes<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Visual impairment</p><p id="ref_1">1. "Product Information. Lupron (leuprolide)." TAP Pharmaceuticals Inc, Deerfield, IL. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Are Lupron Depot and Eligard the same drug?</li>
<li>Will I get my period while on Lupron?</li>
<li>What does this drug do for IVF?</li>
</ul><h2>More about Fensolvi (leuprolide)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>Drug class: gonadotropin releasing hormones</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Precocious Puberty</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>